Skip to content

Collaborators Login

Home
Who We Are
- About Us
What We Do
- Programs & Services
BioIntelligence
News
Contact Us

13th Clinical Trials on Alzheimer’s Disease (CTAD-2020)

Post navigation

Previous: Alzheimer’s Imaging Consortium

Next: ENAM Focus7

Search for:

Recent Posts

Enigma Biomedical – USA Announces Collaboration with Alamar Biosciences to Advance the Field of Diagnostics for Neurodegenerative Diseases
Enigma Biomedical USA Announces Formation of Scientific Advisory Board
Enigma Biomedical USA and the University of Wisconsin
Enigma Biomedical USA, Inc. Announces a Collaboration to Apply Novel 4R PET Imaging Biomarkers to CTE Research

Recent Comments

Archives

February 2026

Categories

PRESS RELEASE

Meta

Log in
Entries feed
Comments feed
WordPress.org

308 N. Peters Road Suite #201
Knoxville, TN 37922

customercare@enigmabiomedicalgroup.com

© Copyright 2026 Enigma Biomedical Inc. All Rights Reserved.

Home
Who We Are
- About Us
What We Do
- Programs & Services
BioIntelligence
News
Contact Us